- Online Patent Information and Document Inspection Service

EP3033101 - Methods for reducing exacerbation rates of asthma using benralizumab

Case Details

Application Number	EP14835826.0
Application Source	European
Publication Number	EP3033101
Publication Language	English
Status	Granted
Filing Date	07 August 2014
Publication Date	22 June 2016
Grant Date	Patent granted with effect from 19 December 2018 (Section 25(1))
Last Renewal Date	15 June 2023
Year of Last Renewal	10
Next Renewal Date	07 August 2024
PCT Application Number	PCT/US2014/050080
PCT Publication Number	WO2015/023504 (Dated 19 February 2015)
Priority Claimed	12 August 2013 in United States of America - Document: 201361864944
Designated States	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Application Title	Methods for reducing exacerbation rates of asthma using benralizumab
Grant Title	Methods for reducing exacerbation rates of asthma using benralizumab
Address for Service	RWS TRANSLATIONS Europa House Chiltern Park^Chiltern Hill Chalfont St Peter Bucks SL9 9FG United Kingdom [ADP Number 10379923001]
Applicant / Proprietor	ASTRAZENECA AB 151 85 Södertälje Sweden [ADP Number 78936465001]
Inventors	CHRISTINE WARD c/o Medlmmune LLC One Medlmmune Way Gaithersburg, MD 20878 United States of America [ADP Number 89764567001] LORIN ROSKOS c/o Medlmmune LLC One Medlmmune Way Gaithersburg, MD 20878 United States of America [ADP Number 89764575001] BING WANG c/o Medlmmune LLC One Medlmmune Way Gaithersburg, MD 20878 United States of America [ADP Number 89764583001] DONALD RAIBLE 317 Lenape Drive Berwyn, PA 19312 United States of America [ADP Number 89764591001]
EPO Representative	ASTRAZENECA INTELLECTUAL PROPERTY Eastbrook House Shaftesbury Road Cambridge CB2 8BF United Kingdom [ADP Number 86998176001]

Select case view

Select the aspect of the case you wish to view: